ORPP logo
Image from Google Jackets

Advanced Nutrition and Dietetics in Obesity.

By: Contributor(s): Material type: TextTextSeries: Advanced Nutrition and Dietetics (BDA) SeriesPublisher: Newark : John Wiley & Sons, Incorporated, 2018Copyright date: ©2018Edition: 1st edDescription: 1 online resource (388 pages)Content type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781118857977
Subject(s): Genre/Form: Additional physical formats: Print version:: Advanced Nutrition and Dietetics in ObesityLOC classification:
  • RA645.O23 .A383 2018
Online resources:
Contents:
Intro -- Title Page -- Copyright Page -- Contents -- Preface -- Foreword -- Editor biographies -- Contributors -- Abbreviations -- Section 1 Introduction -- Chapter 1.1 Definition, prevalence and historical perspectives of obesity in adults -- 1.1.1 Definitions of overweight and obesity -- 1.1.2 Prevalence and trends for obesity in adults -- 1.1.3 Recent history of obesity in adults -- 1.1.4 Genetics of obesity -- 1.1.5 Summary box -- References -- Chapter 1.2 Definition, prevalence and historical perspectives of obesity in children -- 1.2.1 Definition of obesity in children -- 1.2.2 Trends in the prevalence of childhood obesity -- 1.2.3 Conclusion -- 1.2.4 Summary box -- References -- Chapter 1.3 Development of overweight and obesity across the life course -- 1.3.1 Childhood: birth to early school age -- 1.3.2 Adolescence and young adulthood -- 1.3.3 Marriage or cohabitation and body weight -- 1.3.4 Pregnancy -- 1.3.5 Retirement and aging -- 1.3.6 Conclusion -- 1.3.7 Summary box -- References -- Chapter 1.4 Diagnostic criteria and assessment of obesity in adults -- 1.4.1 Indicators of rising body fat content -- 1.4.2 Weight and body mass index (BMI) -- 1.4.3 Waist circumference -- 1.4.4 Diagnosis of obesity by genetic markers -- 1.4.5 Obesity diagnosis with clinical staging -- 1.4.6 Summary box -- References -- Chapter 1.5 Diagnostic criteria and assessment of obesity in children -- 1.5.1 Introduction -- 1.5.2 Diagnosis of overweight and obesity in children and young people -- 1.5.3 Assessment -- 1.5.4 Treatment success criteria -- 1.5.5 Conclusion -- 1.5.6 Summary box -- 1.5.7 Useful tools and websites -- References -- Section 2 Consequences and comorbidities associated with obesity -- Chapter 2.1 Obesity in the development of type 2 diabetes -- 2.1.1 Introduction -- 2.1.2 Diabetes and obesity, the epidemiological relationship.
2.1.3 Epidemiological evidence for both obesity and reduced physical activity -- 2.1.4 Pathophysiological processes linking obesity and type 2 diabetes -- 2.1.5 Influence of ethnicity on obesity and risk of type 2 diabetes -- 2.1.6 Diabetes - the impact of the disease -- 2.1.7 Conclusions -- 2.1.8 Summary box -- References -- Chapter 2.2 Obesity in the development of cardiovascular disease -- 2.2.1 Relationship between BMI and cardiovascular mortality -- 2.2.2 Causes of increased cardiovascular mortality -- 2.2.3 Changes in cardiovascular risk associated with obesity -- 2.2.4 Obesity and cardiovascular risk factors -- 2.2.5 Pathophysiological processes linking obesity and cardiovascular disease -- 2.2.6 Research requirements -- 2.2.7 Summary box -- References -- Chapter 2.3 Obesity as a risk factor in the development of cancer -- 2.3.1 Introduction -- 2.3.2 Obesity and the development of cancer: the epidemiological evidence -- 2.3.3 Pathophysiological processes linking obesity and cancer -- 2.3.4 Weight loss and cancer risk reduction -- 2.3.5 Development of weight loss regimens for cancer risk reduction -- 2.3.6 Recommendations for cancer risk reduction and cancer survivorship -- 2.3.7 Conclusion -- 2.3.8 Summary box -- References -- Chapter 2.4 Obesity as a risk factor in osteoarthritis and pulmonary disease -- 2.4.1 Osteoarthritis - disease pathogenesis and consequences -- 2.4.2 Chronic obstructive pulmonary disease -- 2.4.3 Summary box -- References -- Chapter 2.5 Psychology and mental health issues in obesity -- 2.5.1 Attitudes towards shape and weight vary with time and place -- 2.5.2 Mental health issues and obesity -- 2.5.3 Addressing the mixed messages -- 2.5.4 Conclusion -- 2.5.5 Summary box -- References -- Chapter 2.6 Binge eating and obesity -- 2.6.1 Binge eating and obesity -- 2.6.2 Characteristics of binge eating in obese individuals.
2.6.3 Factors to consider in the development and treatment of binge eating and obesity -- 2.6.4 Summary box -- References -- Section 3 Aetiology of obesity in adults -- 3.1 Genetics and epigenetics in the aetiology of obesity -- 3.1.1 Introduction -- 3.1.2 Monogenic forms of obesity -- 3.1.3 Syndromic obesity -- 3.1.4 Copy number variations -- 3.1.5 Polygenic / multifactorial or common obesity -- 3.1.6 Epigenetic modifications and obesity -- 3.1.7 Genetic factors affecting response to weight loss interventions -- 3.1.8 Genetic testing in obesity -- 3.1.9 Perspectives -- 3.1.10 Summary box -- References -- Chapter 3.2 Food intake and appetite in the aetiology of obesity -- 3.2.1 Introduction -- 3.2.2 Food intake: biology or culture? -- 3.2.3 Food intake, obesity and energy balance -- 3.2.4 The 'satiety cascade' - episodic control of food intake -- 3.2.5 Conclusions -- 3.2.6 Acknowledgements -- 3.2.7 Summary box -- References -- Chapter 3.3 Physiological control of appetite and food intake -- 3.3.1 Introduction -- 3.3.2 Central homeostatic regulation -- 3.3.3 Peripheral homeostatic regulation of energy intake -- 3.3.4 Conclusion -- 3.3.5 Summary box -- References -- Chapter 3.4 Obesogenic medication in the aetiology of obesity -- 3.4.1 Introduction -- 3.4.2 Drugs associated with weight gain -- 3.4.3 Discussion -- 3.4.4 Conclusion -- 3.4.5 Summary box -- References -- Chapter 3.5 Gut microbiome in obesity -- 3.5.1 The gut microbiome -- 3.5.2 Microbiome, obesity and weight loss -- 3.5.3 Metabolic mechanisms of the microbiome in obesity -- 3.5.4 Modifying the microbiome in the management of obesity -- 3.5.5 Conclusion -- 3.5.6 Summary box -- References -- Chapter 3.6 Physical activity and physical inactivity in the aetiology of obesity -- 3.6.1 Introduction -- 3.6.2 Physical activity and body weight: does physical inactivity lead to weight gain?.
3.6.3 Physical fitness and body weight: does being unfit lead to weight gain? -- 3.6.4 Sedentary behaviour and body weight: does being sedentary lead to weight gain? -- 3.6.5 Current physical activity guidelines and their relationship to weight change -- 3.6.6 Summary -- 3.6.7 Summary box -- References -- Chapter 3.7 Obesogenic environment and obesogenic behaviours -- 3.7.1 Introduction -- 3.7.2 Environmental correlates of obesity -- 3.7.3 Conclusion -- 3.7.4 Summary box -- 3.7.5 List of useful websites -- References -- Section 4 Weight management in adults -- Chapter 4.1 Macronutrient composition for weight loss in obesity -- 4.1.1 Carbohydrates and weight loss -- 4.1.2 Fat intake and weight loss -- 4.1.3 Proteins and weight loss -- 4.1.4 Summary and conclusion -- 4.1.5 Summary box -- References -- Chapter 4.2 Meal replacements for weight loss in obesity -- 4.2.1 Introduction -- 4.2.2 Weight loss with meal-replacement plans -- 4.2.3 Weight maintenance with meal-replacement plans -- 4.2.4 Risks of meal-replacement plans -- 4.2.5 Use of meal replacements for weight loss in special populations -- 4.2.6 Conclusion -- 4.2.7 Summary box -- References -- Chapter 4.3 Formula diets for weight loss in obesity -- 4.3.1 Introduction -- 4.3.2 Mechanism of action of formula diets -- 4.3.3 Weight regain and lean body mass loss -- 4.3.4 Potential applications -- 4.3.5 Conclusion -- 4.3.6 Conflict of interest -- 4.3.7 Summary box -- References -- Chapter 4.4 Group-based interventions for weight loss in obesity -- 4.4.1 Introduction -- 4.4.2 Defining group-based interventions for weight management -- 4.4.3 Evidence for obesity interventions delivered in a group setting -- 4.4.4 Evidence for CWM Oprogrammes delivered in a group setting -- 4.4.5 Gender in relation to weight loss groups -- 4.4.6 Important components of group-based approaches in obesity management.
4.4.7 Conclusion -- 4.4.8 Summary box -- References -- Chapter 4.5 Commercial weight management organisations for weight loss in obesity -- 4.5.1 Evidence for effectiveness of CWMOs -- 4.5.2 Conclusion -- 4.5.3 Summary box -- References -- Chapter 4.6 Fad diets and fasting for weight loss in obesity -- 4.6.1 Introduction -- 4.6.2 Popularity of fad diets -- 4.6.3 Classification of fad diets -- 4.6.4 Mechanism of action -- 4.6.5 Advantages of fad diets -- 4.6.6 Disadvantages of fad diets -- 4.6.7 Conclusion -- 4.6.8 Summary box -- References -- Chapter 4.7 Pharmacological management of weight loss in obesity -- 4.7.1 Orlistat -- 4.7.2 Lorcaserin -- 4.7.3 Phentermine/topiramate extended release -- 4.7.4 Glucagon-like peptide-1 (GLP-1) receptor agonists -- 4.7.5 Naltrexone/bupropion -- 4.7.6 Cost-effectiveness of pharmacological interventions in obesity -- 4.7.7 Conclusion -- 4.7.8 Summary box -- References -- Chapter 4.8 Diet to support pharmacological management of weight loss -- 4.8.1 Anti-obesity drugs -- 4.8.2 Diet to support anti-obesitydrugs -- 4.8.3 Conclusion -- 4.8.4 Summary box -- References -- Chapter 4.9 Surgical management of weight loss in obesity -- 4.9.1 Introduction -- 4.9.2 Patient selection, assessment and preparation -- 4.9.3 Surgical and endoscopic procedures -- 4.9.4 Risks and benefits of surgical procedures -- 4.9.5 Selection of weight loss procedure -- 4.9.6 Novel procedures -- 4.9.7 Long-term management -- 4.9.8 Challenges and future developments -- 4.9.9 Summary box -- References -- Chapter 4.10 Diet to support surgical management of weight loss -- 4.10.1 Introduction -- 4.10.2 Preoperative assessment and preparation for surgery -- 4.10.3 Postoperative dietary intervention -- 4.10.4 Impact of bariatric surgery on nutrition -- 4.10.5 Conclusion -- 4.10.6 Summary box -- References.
Chapter 4.11 Physical activity for weight loss in obesity.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Intro -- Title Page -- Copyright Page -- Contents -- Preface -- Foreword -- Editor biographies -- Contributors -- Abbreviations -- Section 1 Introduction -- Chapter 1.1 Definition, prevalence and historical perspectives of obesity in adults -- 1.1.1 Definitions of overweight and obesity -- 1.1.2 Prevalence and trends for obesity in adults -- 1.1.3 Recent history of obesity in adults -- 1.1.4 Genetics of obesity -- 1.1.5 Summary box -- References -- Chapter 1.2 Definition, prevalence and historical perspectives of obesity in children -- 1.2.1 Definition of obesity in children -- 1.2.2 Trends in the prevalence of childhood obesity -- 1.2.3 Conclusion -- 1.2.4 Summary box -- References -- Chapter 1.3 Development of overweight and obesity across the life course -- 1.3.1 Childhood: birth to early school age -- 1.3.2 Adolescence and young adulthood -- 1.3.3 Marriage or cohabitation and body weight -- 1.3.4 Pregnancy -- 1.3.5 Retirement and aging -- 1.3.6 Conclusion -- 1.3.7 Summary box -- References -- Chapter 1.4 Diagnostic criteria and assessment of obesity in adults -- 1.4.1 Indicators of rising body fat content -- 1.4.2 Weight and body mass index (BMI) -- 1.4.3 Waist circumference -- 1.4.4 Diagnosis of obesity by genetic markers -- 1.4.5 Obesity diagnosis with clinical staging -- 1.4.6 Summary box -- References -- Chapter 1.5 Diagnostic criteria and assessment of obesity in children -- 1.5.1 Introduction -- 1.5.2 Diagnosis of overweight and obesity in children and young people -- 1.5.3 Assessment -- 1.5.4 Treatment success criteria -- 1.5.5 Conclusion -- 1.5.6 Summary box -- 1.5.7 Useful tools and websites -- References -- Section 2 Consequences and comorbidities associated with obesity -- Chapter 2.1 Obesity in the development of type 2 diabetes -- 2.1.1 Introduction -- 2.1.2 Diabetes and obesity, the epidemiological relationship.

2.1.3 Epidemiological evidence for both obesity and reduced physical activity -- 2.1.4 Pathophysiological processes linking obesity and type 2 diabetes -- 2.1.5 Influence of ethnicity on obesity and risk of type 2 diabetes -- 2.1.6 Diabetes - the impact of the disease -- 2.1.7 Conclusions -- 2.1.8 Summary box -- References -- Chapter 2.2 Obesity in the development of cardiovascular disease -- 2.2.1 Relationship between BMI and cardiovascular mortality -- 2.2.2 Causes of increased cardiovascular mortality -- 2.2.3 Changes in cardiovascular risk associated with obesity -- 2.2.4 Obesity and cardiovascular risk factors -- 2.2.5 Pathophysiological processes linking obesity and cardiovascular disease -- 2.2.6 Research requirements -- 2.2.7 Summary box -- References -- Chapter 2.3 Obesity as a risk factor in the development of cancer -- 2.3.1 Introduction -- 2.3.2 Obesity and the development of cancer: the epidemiological evidence -- 2.3.3 Pathophysiological processes linking obesity and cancer -- 2.3.4 Weight loss and cancer risk reduction -- 2.3.5 Development of weight loss regimens for cancer risk reduction -- 2.3.6 Recommendations for cancer risk reduction and cancer survivorship -- 2.3.7 Conclusion -- 2.3.8 Summary box -- References -- Chapter 2.4 Obesity as a risk factor in osteoarthritis and pulmonary disease -- 2.4.1 Osteoarthritis - disease pathogenesis and consequences -- 2.4.2 Chronic obstructive pulmonary disease -- 2.4.3 Summary box -- References -- Chapter 2.5 Psychology and mental health issues in obesity -- 2.5.1 Attitudes towards shape and weight vary with time and place -- 2.5.2 Mental health issues and obesity -- 2.5.3 Addressing the mixed messages -- 2.5.4 Conclusion -- 2.5.5 Summary box -- References -- Chapter 2.6 Binge eating and obesity -- 2.6.1 Binge eating and obesity -- 2.6.2 Characteristics of binge eating in obese individuals.

2.6.3 Factors to consider in the development and treatment of binge eating and obesity -- 2.6.4 Summary box -- References -- Section 3 Aetiology of obesity in adults -- 3.1 Genetics and epigenetics in the aetiology of obesity -- 3.1.1 Introduction -- 3.1.2 Monogenic forms of obesity -- 3.1.3 Syndromic obesity -- 3.1.4 Copy number variations -- 3.1.5 Polygenic / multifactorial or common obesity -- 3.1.6 Epigenetic modifications and obesity -- 3.1.7 Genetic factors affecting response to weight loss interventions -- 3.1.8 Genetic testing in obesity -- 3.1.9 Perspectives -- 3.1.10 Summary box -- References -- Chapter 3.2 Food intake and appetite in the aetiology of obesity -- 3.2.1 Introduction -- 3.2.2 Food intake: biology or culture? -- 3.2.3 Food intake, obesity and energy balance -- 3.2.4 The 'satiety cascade' - episodic control of food intake -- 3.2.5 Conclusions -- 3.2.6 Acknowledgements -- 3.2.7 Summary box -- References -- Chapter 3.3 Physiological control of appetite and food intake -- 3.3.1 Introduction -- 3.3.2 Central homeostatic regulation -- 3.3.3 Peripheral homeostatic regulation of energy intake -- 3.3.4 Conclusion -- 3.3.5 Summary box -- References -- Chapter 3.4 Obesogenic medication in the aetiology of obesity -- 3.4.1 Introduction -- 3.4.2 Drugs associated with weight gain -- 3.4.3 Discussion -- 3.4.4 Conclusion -- 3.4.5 Summary box -- References -- Chapter 3.5 Gut microbiome in obesity -- 3.5.1 The gut microbiome -- 3.5.2 Microbiome, obesity and weight loss -- 3.5.3 Metabolic mechanisms of the microbiome in obesity -- 3.5.4 Modifying the microbiome in the management of obesity -- 3.5.5 Conclusion -- 3.5.6 Summary box -- References -- Chapter 3.6 Physical activity and physical inactivity in the aetiology of obesity -- 3.6.1 Introduction -- 3.6.2 Physical activity and body weight: does physical inactivity lead to weight gain?.

3.6.3 Physical fitness and body weight: does being unfit lead to weight gain? -- 3.6.4 Sedentary behaviour and body weight: does being sedentary lead to weight gain? -- 3.6.5 Current physical activity guidelines and their relationship to weight change -- 3.6.6 Summary -- 3.6.7 Summary box -- References -- Chapter 3.7 Obesogenic environment and obesogenic behaviours -- 3.7.1 Introduction -- 3.7.2 Environmental correlates of obesity -- 3.7.3 Conclusion -- 3.7.4 Summary box -- 3.7.5 List of useful websites -- References -- Section 4 Weight management in adults -- Chapter 4.1 Macronutrient composition for weight loss in obesity -- 4.1.1 Carbohydrates and weight loss -- 4.1.2 Fat intake and weight loss -- 4.1.3 Proteins and weight loss -- 4.1.4 Summary and conclusion -- 4.1.5 Summary box -- References -- Chapter 4.2 Meal replacements for weight loss in obesity -- 4.2.1 Introduction -- 4.2.2 Weight loss with meal-replacement plans -- 4.2.3 Weight maintenance with meal-replacement plans -- 4.2.4 Risks of meal-replacement plans -- 4.2.5 Use of meal replacements for weight loss in special populations -- 4.2.6 Conclusion -- 4.2.7 Summary box -- References -- Chapter 4.3 Formula diets for weight loss in obesity -- 4.3.1 Introduction -- 4.3.2 Mechanism of action of formula diets -- 4.3.3 Weight regain and lean body mass loss -- 4.3.4 Potential applications -- 4.3.5 Conclusion -- 4.3.6 Conflict of interest -- 4.3.7 Summary box -- References -- Chapter 4.4 Group-based interventions for weight loss in obesity -- 4.4.1 Introduction -- 4.4.2 Defining group-based interventions for weight management -- 4.4.3 Evidence for obesity interventions delivered in a group setting -- 4.4.4 Evidence for CWM Oprogrammes delivered in a group setting -- 4.4.5 Gender in relation to weight loss groups -- 4.4.6 Important components of group-based approaches in obesity management.

4.4.7 Conclusion -- 4.4.8 Summary box -- References -- Chapter 4.5 Commercial weight management organisations for weight loss in obesity -- 4.5.1 Evidence for effectiveness of CWMOs -- 4.5.2 Conclusion -- 4.5.3 Summary box -- References -- Chapter 4.6 Fad diets and fasting for weight loss in obesity -- 4.6.1 Introduction -- 4.6.2 Popularity of fad diets -- 4.6.3 Classification of fad diets -- 4.6.4 Mechanism of action -- 4.6.5 Advantages of fad diets -- 4.6.6 Disadvantages of fad diets -- 4.6.7 Conclusion -- 4.6.8 Summary box -- References -- Chapter 4.7 Pharmacological management of weight loss in obesity -- 4.7.1 Orlistat -- 4.7.2 Lorcaserin -- 4.7.3 Phentermine/topiramate extended release -- 4.7.4 Glucagon-like peptide-1 (GLP-1) receptor agonists -- 4.7.5 Naltrexone/bupropion -- 4.7.6 Cost-effectiveness of pharmacological interventions in obesity -- 4.7.7 Conclusion -- 4.7.8 Summary box -- References -- Chapter 4.8 Diet to support pharmacological management of weight loss -- 4.8.1 Anti-obesity drugs -- 4.8.2 Diet to support anti-obesitydrugs -- 4.8.3 Conclusion -- 4.8.4 Summary box -- References -- Chapter 4.9 Surgical management of weight loss in obesity -- 4.9.1 Introduction -- 4.9.2 Patient selection, assessment and preparation -- 4.9.3 Surgical and endoscopic procedures -- 4.9.4 Risks and benefits of surgical procedures -- 4.9.5 Selection of weight loss procedure -- 4.9.6 Novel procedures -- 4.9.7 Long-term management -- 4.9.8 Challenges and future developments -- 4.9.9 Summary box -- References -- Chapter 4.10 Diet to support surgical management of weight loss -- 4.10.1 Introduction -- 4.10.2 Preoperative assessment and preparation for surgery -- 4.10.3 Postoperative dietary intervention -- 4.10.4 Impact of bariatric surgery on nutrition -- 4.10.5 Conclusion -- 4.10.6 Summary box -- References.

Chapter 4.11 Physical activity for weight loss in obesity.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.

There are no comments on this title.

to post a comment.

© 2024 Resource Centre. All rights reserved.